Edit |   |
---|---|
Antigenic Specificity | SELP, Human (Inclacumab biosimilar) |
Clone | Inclacumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC, Inhib, Agonist, Activ |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human SELP Recombinant Antibody (Inclacumab). Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease. The antibody is outlicensed by Roche. |
Immunogen | n/a |
Other Names | Anti-SELP Recombinant Antibody, Research Grade Inclacumab, Anti-Human SELP Recombinant Antibody(Inclacumab), LC1004-002, RO4905417, Antibody Drug Analogues, Monoclonal Antibody, YR1266, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1256258-86-2 |
Catalog # | YR1266 |
Price | please inquire |
Order / More Info | SELP, Human (Inclacumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |